8
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T6252 | Ipatasertib | GDC-0068,RG7440 | Akt |
Ipatasertib (GDC-0068) (GDC-0068), a highly specific pan-Akt inhibitor, targets Akt1/2/3 with IC50 of 5 nM/18 nM/8 nM, respectively. | |||
T15374 | Ipatasertib dihydrochloride | GDC-0068 dihydrochloride,RG-7440 dihydrochloride | Akt , PKA |
Ipatasertib dihydrochloride (GDC-0068 dihydrochloride) is a highly selective and ATP-competitive inhibitor of pan-Akt (IC50s: 5, 18 and 8 nM for Akt1, Akt2 and Akt3, respectively). | |||
T38393 | Ipatasertib-NH2 dihydrochloride | RG7440-NH2 dihydrochloride,Ipatasertib-NH2 dihydrochloride,GDC-0068-NH2 dihydrochloride | |
Ipatasertib-NH2 dihydrochloride is a ligand for the target protein AKT in PROTAC INY-03-041. INY-03-041 consists of Ipatasertib-NH2, a ten-hydrocarbon linker, and the CRBN ligand Lenalidomide, which acts as an E3 ubiquit... | |||
T70552 | Ipatasertib tosylate | ||
Ipatasertib, also known as GDC0068, is an orally active, potent and selective Akt inhibitor. GDC-0068 blocked Akt signaling both in cultured human cancer cell lines and in tumor xenograft models. Inhibition of Akt acti... | |||
T27621 | Ipatasertib HCl | GDC0068,RG 7440,GDC 0068,RG-7440,GDC-0068,RG7440 | |
Ipatasertib is an orally active, potent and selective Akt inhibitor with antitumor activity. Inhibition of Akt activity by Ipatasertib resulted in blockade of cell-cycle progression and reduced viability of cancer cell l... | |||
T18053 | Ipatasertib-NH2 | RG7440-NH2,GDC-0068-NH2 | Others |
Ipatasertib-NH2 (GDC-0068-NH2;RG7440-NH2) is a ligand for target protein AKT for PROTAC, binds to lenalidomide, a ligand of ubiquitin E3 ligase cereblon (CRBN), via a ten-hydrocarbon linker to form INY-03-041 to degrade ... | |||
T70550 | BMS-986034 | ||
BMS-986034 is a GPR119 agonist. | |||
T74001 | INY-03-041 trihydrochloride | ||
INY-03-041 trihydrochloride, a potent and highly selective PROTAC-based pan-AKT degrader, comprises Ipatasertib, an ATP-competitive AKT inhibitor, conjugated to Lenalidomide. It effectively inhibits AKT1, AKT2, and AKT3 ... |